Raia Drogasil S.A.
RADLY
$2.86
-$0.319-10.05%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -4.29% | 1.28% | 9.03% | 20.43% | 20.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.29% | 1.28% | 9.03% | 20.43% | 20.91% |
| Cost of Revenue | -3.64% | 1.44% | 10.05% | 20.52% | 21.00% |
| Gross Profit | -5.80% | 0.89% | 6.73% | 20.21% | 20.69% |
| SG&A Expenses | -5.63% | -2.38% | 8.31% | 18.25% | 25.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 140.85% | 149.63% | 518.21% | 117.90% | -707.20% |
| Total Operating Expenses | -2.94% | 1.30% | 9.75% | 20.01% | 20.80% |
| Operating Income | -24.79% | 0.87% | -0.05% | 27.66% | 22.56% |
| Income Before Tax | -20.00% | 28.49% | -5.09% | 44.41% | 7.03% |
| Income Tax Expenses | -442.88% | 165.86% | 13.12% | 1,550.34% | 248.97% |
| Earnings from Continuing Operations | 6.00% | 11.24% | -8.98% | 2.46% | 2.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 100.59% | 19.08% | 60.37% | 0.01% | -672.61% |
| Net Income | 13.04% | 11.76% | -8.23% | 2.53% | -2.91% |
| EBIT | -24.79% | 0.87% | -0.05% | 27.66% | 22.56% |
| EBITDA | -20.61% | -0.56% | 0.22% | 23.89% | 19.52% |
| EPS Basic | 17.59% | 14.38% | -46.32% | 6.48% | -3.15% |
| Normalized Basic EPS | -26.61% | 11.50% | -40.75% | 53.33% | 16.98% |
| EPS Diluted | 17.59% | 13.75% | -46.32% | 7.08% | -2.85% |
| Normalized Diluted EPS | -26.61% | 10.62% | -40.75% | 55.30% | 16.98% |
| Average Basic Shares Outstanding | -3.84% | -2.33% | 71.24% | -3.79% | 0.10% |
| Average Diluted Shares Outstanding | -3.84% | -1.74% | 71.24% | -4.70% | -0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.26% | 1.89% | 0.09% | 7.67% | 0.15% |
